Showing results (211-220 of 237) with videos related to
Sort By:
Pageof 24
Proceedings of the National Academy of Sciences of the United States of America|July 1, 2020
Sex differences in neutrophil biology modulate response to type I interferons and immunometabolismSarthak Gupta, Shuichiro Nakabo, Luz P Blanco, et al.Cell Reports|October 19, 2022
SARS-CoV-2 infections elicit higher levels of original antigenic sin antibodies compared with SARS-CoV-2 mRNA vaccinationsElizabeth M Anderson, Shuk Hang Li, Moses Awofolaju, et al.Medrxiv : the Preprint Server for Health Sciences|September 28, 2021
Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individualsKatlyn Lederer, Kalpana Parvathaneni, Mark M Painter, et al.Current Oncology (Toronto, Ont.)|July 24, 2010
Eastern Canadian Colorectal Cancer Consensus Conference: setting the limits of resectable diseaseM Vickers, B Samson, B Colwell, et al.Medrxiv : the Preprint Server for Health Sciences|March 10, 2021
Longitudinal Analysis Reveals Distinct Antibody and Memory B Cell Responses in SARS-CoV2 Naïve and Recovered Individuals Following mRNA VaccinationRishi R Goel, Sokratis A Apostolidis, Mark M Painter, et al.Current Oncology (Toronto, Ont.)|January 5, 2017
Eastern Canadian Gastrointestinal Cancer Consensus Conference 2016D Bossé, T Ng, C Ahmad, et al.Current Oncology (Toronto, Ont.)|November 12, 2019
Eastern Canadian Gastrointestinal Cancer Consensus Conference 2018A J Hyde, R Nassabein, A AlShareef, et al.Current Oncology (Toronto, Ont.)|March 12, 2016
Eastern Canadian Colorectal Cancer Consensus Conference 2013: emerging therapies in the treatment of pancreatic, rectal, and colorectal cancersT Di Valentin, T Asmis, J Asselah, et al.Cell Reports|October 16, 2022
A boost with SARS-CoV-2 BNT162b2 mRNA vaccine elicits strong humoral responses independently of the interval between the first two dosesAlexandra Tauzin, Shang Yu Gong, Debashree Chatterjee, et al.Cell|February 24, 2022
Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individualsKatlyn Lederer, Emily Bettini, Kalpana Parvathaneni, et al.Pageof 24